![](/img/cover-not-exists.png)
Herpes Simplex Virus (HSV)-2 Candidate Vaccine Virus Deleted in Glycoprotein D (ΔgD-2) Elicits High-Titer Immunoglobulin (Ig)G2 Antibodies With Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Activity, Protects Mice From Skin and Vaginal Challenge With Clinical Isolates of HSV-1 and HSV-2, and Prevents the Establishment of Latency
Herold, Betsy C., Petro, Christopher, Burn, Clare, Weiss, Kayla, Ramsey, Natalie, Weinrick, Brian, Jacobs, WilliamVolume:
3
Language:
english
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofw194.69
Date:
December, 2016
File:
PDF, 47 KB
english, 2016